Aki Koivistoinen

Aki Koivistoinen has a diverse work experience spanning different industries such as healthcare, finance, and technology. Aki has held various roles in different companies, demonstrating their expertise in advisory, leadership, and entrepreneurship.

In 2016, Aki served as the Director of StartUp Health Finland, where they coached and supported digital health entrepreneurs. Aki also worked as a StartUp Health Ambassador for Europe and Israel, promoting the organization's mission to improve global health and wellbeing.

Additionally, Aki has been an advisor and angel investor for hi.health, a company that combines insurance and secure payment methods. Aki also served as a member of the advisory board and angel investor for MONI Limited, a fast and secure financial technology company.

Furthermore, Aki has made contributions to companies like AskKauko and WEOPTIT as a member of their advisory boards, providing insights to measure and communicate impact and optimizing AI and big data analytics projects respectively.

Aki has also played significant roles in their own ventures, co-founding and serving as chairman of the board for EGIREI Kft and as a partner in Property Consortium Koivistoinen Aki, Juha & Olli. Additionally, they co-founded Karyon Ltd, a medical biotech company focusing on imaging and treatment of solid tumors.

Before venturing into entrepreneurship, Aki worked as a researcher at Helsinki University Central Hospital & Helsinki University Department of Biochemistry.

Overall, Aki Koivistoinen's work experience showcases their versatility and expertise in startups, entrepreneurship, advisory roles, and the healthcare sector.

Aki Koivistoinen completed a Bachelor of Science degree in Biochemistry from the University of Eastern Finland in 1999. In addition, they pursued further studies in Biotechnology at the University of Glasgow from 1997 to 1998. Aki also obtained a certification as a Certified Professional Facilitator from the International Association of Facilitators (IAF) in October 2011.